Managing the adverse events of immune checkpoint inhibitors

preview_player
Показать описание
Immune checkpoint inhibitors are effective in the management of various cancers. However, there are a number of side effects that are linked to the long-term use of these agents, including colitis and myocarditis. Here, Christopher Campen, PharmD, BCOP, from the GHS Cancer Institute, Greenville, SC, discusses the management of the related toxicity and the steps that can be taken to reduce these effects. This video was recorded at the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference held in Denver, CO.
  1. VJOncology
  2. Speaker: Christopher Campen
  3. Event: HOPA 2018
  4. Format: Interview
  5. Subject: General
  6. Field: Supportive Care
Рекомендации по теме
Managing the adverse 0:01:57

Managing the adverse events of immune checkpoint inhibitors

Management of Adverse 0:21:53

Management of Adverse Events with Newer Therapeutic Approaches

Managing Adverse Events 0:12:53

Managing Adverse Events with New Therapeutic Approaches

Identifying and managing 0:00:45

Identifying and managing adverse events of fruquintinib for CRC

Management of adverse 0:01:05

Management of adverse events from datopotamab deruxtecan in NSCLC

Dr. Puzanov on 0:02:12

Dr. Puzanov on Management of Adverse Events in Melanoma

Managing Immune-Related Adverse 0:51:21

Managing Immune-Related Adverse Events | Free Online CME

Monitoring, managing, and 0:21:59

Monitoring, managing, and mitigating immune-related adverse events

BTK Inhibitors for 0:31:34

BTK Inhibitors for Chronic Lymphocytic Leukemia: Pharmacist Viewpoints

What are adverse 0:01:40

What are adverse events in relation to vaccination and how are they managed? | Wellcome

Managing adverse events 0:01:34

Managing adverse events with novel therapies in lower-risk MDS

Managing Adverse Events 0:26:28

Managing Adverse Events with Susanna Stanford and Sarah Seddon

Improving management of 0:02:12

Improving management of adverse events in CAR-T patients

Management of Adverse 0:14:45

Management of Adverse Effects in R/R HER2+ mBC

Management of immune-related 0:08:42

Management of immune-related adverse events in ICI therapy

Management of BTK 0:04:22

Management of BTK class driven adverse events

Managing Thyroid Adverse 0:26:03

Managing Thyroid Adverse Events From Checkpoint Inhibitors

HCC Whiteboard #3: 0:03:12

HCC Whiteboard #3: The Management of Adverse Events of Tyrosine Kinase Inhibitors

HCC: Management of 0:12:53

HCC: Management of Adverse Events with New Therapeutic Approaches

Management of adverse 0:22:35

Management of adverse events with newer agents for CLL

PARPi: Management of 0:53:08

PARPi: Management of Adverse Events (2024)

The management of 0:03:25

The management of BTK-driven adverse events

Adverse Events Management 1:36:42

Adverse Events Management in Clinical Drug Trials

Managing Adverse Events 0:36:12

Managing Adverse Events and Concomitant Medications within Epic